A client who has just been diagnosed with mixed muscular dystrophy asks the nurse about the usual course of this disease.
How should the nurse respond?
"You may experience progressive deterioration in all voluntary muscles.”.
"The strength of your arms and pelvic muscles will decrease gradually, but this should cause only slight disability.”.
"You should ask your health care provider about that.”.
"This form of muscular dystrophy is a relatively benign disease that progresses slowly.”. .
The Correct Answer is A
Choice A rationale
Mixed muscular dystrophy leads to progressive deterioration in all voluntary muscles, causing increasing disability over time.
Choice B rationale
This statement is incorrect because mixed muscular dystrophy affects more than just the arms and pelvic muscles and leads to significant disability.
Choice C rationale
This is not an appropriate response as it does not provide any information and deflects the client's question.
Choice D rationale
Mixed muscular dystrophy is not considered benign, as it causes significant and progressive muscle deterioration.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
Percutaneous absorption of topical corticosteroids increases systemic exposure, potentially causing side effects like adrenal suppression, hyperglycemia, and Cushing's syndrome. This is particularly significant when potent corticosteroids are applied to large body areas or under occlusive dressings, enhancing absorption and systemic effects.
Choice B rationale
Topical corticosteroids primarily induce vasoconstriction, not vasodilation, reducing inflammation and redness in skin conditions. Incorrect understanding of their vasodilatory effects may misguide nursing interventions, making it less relevant to the injury risk in atopic dermatitis treatments.
Choice C rationale
Topical corticosteroids have minimal systemic interactions compared to oral or intravenous forms, making drug interaction concerns less pertinent. The risk of significant drug interactions is low unless the medication is systemically absorbed in substantial amounts.
Choice D rationale
Application to face, neck, and intertriginous sites increases the risk of local side effects like skin atrophy, but is not a primary concern for systemic injury risk. These areas have thinner skin, enhancing absorption and risk of local adverse effects, but not necessarily systemic harm.
Correct Answer is ["B","C","D"]
Explanation
Choice A rationale
Tachycardia is not a symptom of Cushing's triad; it is often associated with other conditions such as stress or heart problems.
Choice B rationale
Bradypnea is a hallmark of Cushing's triad, indicating decreased respiratory rate due to increased intracranial pressure.
Choice C rationale
Hypertension is a key component of Cushing's triad, caused by increased intracranial pressure leading to elevated blood pressure.
Choice D rationale
Bradycardia, or a slower than normal heart rate, is a symptom of Cushing's triad, resulting from increased pressure in the brain affecting the heart rate.
Choice E rationale
Pupillary constriction is not typically associated with Cushing's triad; it is usually related to other neurological conditions.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.